Navigation Links
Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA

the BiTE molecule targeting EphA2 killed tumor cells at dose levels considerably below those required by classical monoclonal antibody-based therapies in in vivo and in vitro proof-of-concept studies.

"The EphA2 and CEA antigens are the focus of ongoing preclinical research within MedImmune's broad pipeline of potential treatments for cancer," said Peter Kiener, MedImmune's Senior Vice President, Research. "Both have been implicated in the growth and survival of a range of tumor types, and we are encouraged by the preclinical study results to date with these two highly potent BiTE molecules."

About BiTE(R) Molecules

BiTE molecules are a novel class of antibody derivatives with the potential to selectively direct and activate an individual's cytotoxic T cells, the body's most potent killer cells, to act against cancer cells. MT103/MEDI-538, a BiTE molecule targeting the B cell antigen CD19, provided clinical proof-of-concept for the BiTE platform technology, as presented at the last meeting of the American Society for Hematology. In an ongoing phase 1 study, MT103/MEDI-538 has shown potent elimination of tumor target cells in peripheral blood, bone marrow, lymph nodes and spleen of therapy-refractory non-Hodgkins lymphoma patients.

About MedImmune, Inc.

MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious disease, cancer and inflammatory diseases. With more than 2,500 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at http://www.medimmune.com.

About Micromet, Inc. (http://www.micromet-inc.com)

Micromet, Inc.
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
2. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
3. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
4. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
5. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
6. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
7. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
8. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
9. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
10. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
11. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR

Post Your Comments:
(Date:11/25/2009)... According to Millennium Research ...ology market intelligence, the nearly $3 billion U... to see rapid growth over the next five years desp...s for Trauma Devices 2010 report finds that thi...five years, with competitors introducing specializ...
(Date:11/25/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Pain Management - Global Trends ,,...ment---Global-Trends.html ,, Widespread availa...ent clinics, and the advent of new drugs have acce...market. Healthcare reforms and reimbursement struc...
(Date:11/25/2009)...Y, Nov. 25 HeartWare Int...ding innovator and provider of less invasive, mini...onizing the treatment of advanced heart failure, t...estor presentation at the 21st Annual Piper Jaffra...ay, December 2, 2009. The conference is being held...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2iTech Medical Provides Update on MPR Clinical Development Plan 58632 1iTech Medical Provides Update on MPR Clinical Development Plan 58632 2iTech Medical Provides Update on MPR Clinical Development Plan 58632 3iTech Medical Provides Update on MPR Clinical Development Plan 58632 4Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 1Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 2Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 3Lumenis 28R 29 Introduces AcuPulse 28TM 29 for Fractional Laser Treatments 5131 4Prix Galien USA Honors Innovation in Science and Biotech Industries 5128 1Prix Galien USA Honors Innovation in Science and Biotech Industries 5128 2
..., Calif., June 04, 2007 /PRNewswire-FirstCall/ --,... positive Phase 2,results for the treatment of hot...d seventeen women were enrolled in the company,s,d... 2 trial.,Postmenopausal women with 50 or more mod...ed to one of three treatment groups receiving,MF10...
...pecified subset analyses of progression-free survi...trate a reduction in,relative risk of disease prog...analyses included prior Taxotere use,geographies,... June 04, 2007 /PRNewswire-FirstCall/ -- Pharmion,... presentation of,additional data from the double-b...
Other Medicine Technology:Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 2Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 3Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7
(Date:11/28/2009)...pirits, recognize signs of depression , ,...eniors, the holiday season can trigger melancholy ... health issues or worry about money problems, acco...help overcome the seasonal blues, the AGS Foundati...: , Get out and socialize or invite family and f...
(Date:11/27/2009)... The Gymboree Corporatio...FO/COO, will present at the NASDAQ OMX 23rd Invest...el in London, England, on Wednesday, December 2, 2...broadcast of The Gymboree Corporation,s presentati...e.com, click on "Our Company" at the bottom of the...
(Date:11/27/2009)...sion vehicles may reduce future disease burden, re...hDay News) -- Encouraging city dwellers to walk an...reater public health benefits than increased used ...und. , The study compared the projected health ...t scenarios for London, England, and Delhi, India:...
(Date:11/27/2009)...ist manufacturers who use medical load cells at th...ollars by bringing in technology partner Flintec e...pro-active medical manufacturers are calling in Fl...eir projects, ensuring that progress will not be c...ally outdated technology. , ...
(Date:11/26/2009)...trathiomolybdate (TM) has been shown in studies to...a disease caused by an overload of copper, and cer...little, however, is known about how the drug works...rthwestern University researchers now has provided...re of TM bound to copper-loaded metallochaperones....
Breaking Medicine News(10 mins):Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...8 Perhaps signaling,donors, fears of a weakening ...c giving for health care in the United States fell...nadian rate of growth in donations to,health care ...stems in both countries are relying more,and more ...
... the non-surgical solution to rejuvenate, restore ...el, MD, is revolutionizing,the field of aesthetic ...e,procedure that restores and improves the appeara... Dr. Trokel, a cosmetic surgeon, the face is like ...
...S, HOME PHOTOS HELP IDENTIFY ASTHMA TRIGGERS , (Mo...me photography may be a more cost-effective altern...a and allergy triggers. Researchers from Truman Me... of areas in their home using a disposable camera....
... ABUSE BY US TROOPS IN IRAQ TWICE NATIONAL AVERAGE...nce of tobacco use by US military deployed to Iraq...er Michael A. Wilson of the United States Navy sur...nt) of the Marines and sailors surveyed used some ...
...atient Advocates Link Underrepresentation of,Minor... HOUSTON, Oct. 28 What is keeping so many,America...m taking part in,medical studies for diseases from...representation of women, older,adults, and minorit...
.... 28 URAC,s Board of,Directors has approved quali...orkers, Compensation and Property and Casualty Pha...t addition to URAC,s Pharmacy Quality,Management(R...y URAC,s,Pharmacy Accreditation Advisory Group, wh...
Other Medicine News:Health News:Growth Rate of U.S. Giving for Health Care Falls More Than 50 Percent in 2007 But Rises Almost Threefold in Canada, According to Association for Healthcare Philanthropy's Annual 'Report on Giving' 2Health News:Growth Rate of U.S. Giving for Health Care Falls More Than 50 Percent in 2007 But Rises Almost Threefold in Canada, According to Association for Healthcare Philanthropy's Annual 'Report on Giving' 3Health News:The Y Lift 2Health News:New research about chronic lung disease presented at CHEST 2008 2Health News:New research about chronic lung disease presented at CHEST 2008 3Health News:New research about chronic lung disease presented at CHEST 2008 4Health News:New research about chronic lung disease presented at CHEST 2008 5Health News:New research about chronic lung disease presented at CHEST 2008 6Health News:New research about chronic lung disease presented at CHEST 2008 7Health News:CHEST 2008: New research related to tobacco use 2Health News:Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing 'Tuskegee Effect' When Recruiting Minorities for Research Studies 2Health News:Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing 'Tuskegee Effect' When Recruiting Minorities for Research Studies 3Health News:Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing 'Tuskegee Effect' When Recruiting Minorities for Research Studies 4Health News:Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing 'Tuskegee Effect' When Recruiting Minorities for Research Studies 5Health News:URAC Introduces New Pharmacy Benefit Management Accreditation for Workers' Compensation and Property and Casualty Programs 2
Maxenon Xi 300
TrueView Sport
TrueView Classic
High Lite Sport
Medicine Products: